Alkermes (ALKS) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts ALKS Hot Sheet
Price: $24.44 -0.85%
Revenue Growth %: +26.3%
Financial Fact:
Total other income (expense), net: -1.64M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +26.3%
Financial Fact:
Total other income (expense), net: -1.64M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q2 EPS of $0.30, $0.08 better than the analyst estimate of $0.22. Revenue for the quarter came in at $138.6 million versus the consensus estimate of $131.5 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Tenaris SA (TS) Tops Q1 EPS by 22c; offers outlook
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
